Spyre Therapeutics Inc
NASDAQ:SYRE

Watchlist Manager
Spyre Therapeutics Inc Logo
Spyre Therapeutics Inc
NASDAQ:SYRE
Watchlist
Price: 16.97 USD 2.11%
Market Cap: 1B USD

Wall Street
Price Targets

SYRE Price Targets Summary
Spyre Therapeutics Inc

Wall Street analysts forecast SYRE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYRE is 55.65 USD with a low forecast of 27.27 USD and a high forecast of 74.55 USD.

Lowest
Price Target
27.27 USD
61% Upside
Average
Price Target
55.65 USD
228% Upside
Highest
Price Target
74.55 USD
339% Upside
Spyre Therapeutics Inc Competitors:
Price Targets
CPRX
Catalyst Pharmaceuticals Inc
34% Upside
688520
Sinocelltech Group Ltd
18% Upside
688331
RemeGen Co Ltd
25% Downside
NVAX
Novavax Inc
126% Upside
SPRO
Spero Therapeutics Inc
104% Upside
FHTX
Foghorn Therapeutics Inc.
142% Upside
688105
Nanjing Vazyme Biotech Co Ltd
8% Upside
CRNX
Crinetics Pharmaceuticals Inc
129% Upside

Revenue
Forecast

Revenue Estimate
Spyre Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Spyre Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Spyre Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SYRE's stock price target?
Price Target
55.65 USD

According to Wall Street analysts, the average 1-year price target for SYRE is 55.65 USD with a low forecast of 27.27 USD and a high forecast of 74.55 USD.

Back to Top